Personalized medicine strategies for managing patients with Parkinsonism and cognitive deficits

Metabolism: Clinical and Experimental

Volumn 62, Issue SUPPL.1, 2013, Pages

  Wurtman, Richard J ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Alzheimer's disease; Frontotemporal dementia; Genetic biomarkers; Huntington's disease; Imaging biomarkers

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID PRECURSOR PROTEIN; DOPAMINE; LEUCINE RICH REPEAT KINASE 2;

AMYLOID PLAQUE; ARTICLE; COGNITIVE DEFECT; DENDRITIC SPINE; DIFFUSE LEWY BODY DISEASE; DIFFUSION TENSOR IMAGING; DISEASE COURSE; DISEASE SEVERITY; DOPAMINE BRAIN LEVEL; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; GENETIC SCREENING; HUMAN; HUNTINGTON CHOREA; LEWY BODY; MYENTERIC PLEXUS; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PARKINSONISM; PERSONALIZED MEDICINE; PRIORITY JOURNAL; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SLEEP DISORDER; SUBSTANTIA NIGRA; TREATMENT RESPONSE; VISUAL HALLUCINATION;

ALPHA-SYNUCLEIN; ALZHEIMER DISEASE; ANTIPARKINSON AGENTS; BIOLOGICAL MARKERS; COGNITION; COGNITION DISORDERS; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; FRONTOTEMPORAL DEMENTIA; GENETIC MARKERS; GENETIC TESTING; GLUCOSYLCERAMIDASE; HUMANS; HUNTINGTON DISEASE; INDIVIDUALIZED MEDICINE; LEVODOPA; LEWY BODY DISEASE; MUTATION; PARKINSON DISEASE; PROTEIN-SERINE-THREONINE KINASES;

EID: 84870485649     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2012.08.025     Document Type: Article

References (21)

1. R. Mayeux, J. Denaro, and N. Hemenegildo A population-based investigation of Parkinson's disease with and without dementia. Relationship to age and gender Arch Neurol 49 1992 492 497
2. D. Muslimovic, B. Post, and J.D. Speelman Cognitive profile of patients with newly diagnosed Parkinson disease Neurology 65 2005 1239 1245
3. C.F. Lippa, and Grossman M. Duda JE DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers Neurology 68 2007 812 819
4. S. Molloy, I.G. McKeith, and J.T. O'Brien The role of levodopa in the management of dementia with Lewy bodies J Neurol Neurosury Psychiatry 76 2005 1200 1203
5. I. McKeith, J. Mintzer, and D. Aarsland Dementia with Lewy bodies Lancet Neurol 3 2004 19 21
6. K. Bronnick, U. Ehrt, and M. Emre Attentional deficits affect activities of daily living in dementia-associated with Parkinson's disease J Neuro Neurosurg Psychiatry 77 2006 1136 1142
7. L.G. McKeith, D. Galasko, and K. Kosaka Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop Neurology 47 1996 1113 1124
8. B. Dubois, H.H. Feldman, and C. Jacova Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria Lancet Neurol 6 2007 734 746
9. C.M. Clark, J.A. Schneider, and B.J. Bedell Use of Florbetapir-PET for imaging β-amyloid pathology JAMA 305 2011 275 283
10. M.L. Kramer, and W.J. Schulz-Schaeffer Presdynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies J Neurosci 27 2007 1405 1410
11. G.M. Shankar, S. Li, and T.H. Mehta Amyloid-beta protein dimmers isolated directly from Alzheimer's brains impair synaptic plasticity and memory Nat Med 14 2008 837 842
12. R.M. Koffie, M. Meyer-Luehmann, and T. Hashimoto Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques PNAS 1 2007 4012 4017
13. D.J. Braak, and K. Del Tredici Nervous system pathology I sporadic Parkinson's disease Neurology 2008 1916 70
14. E. Maries, B. Dass, and T.J. Collier The role of alpha-synuclein in Parkinson's disease: insights from animal models Nat Rev Neurosci 4 2003 727 738
15. C. Klein, and M.G. Schlossmacher Parkinson disease, 10 years after its genetic revolution: multiple clues to a complex disorder Neurology 69 2007 2093 2104
16. E.K. Tan, and J. Jankovic Genetic testing in Parkinson disease: promises and pitfalls Arch Neurol 63 2006 1232 1237
17. C.S. Wang, J.R. Burke, and D.C. Steffens Twin pairs discordant for neuropathologically confirmed Lewy body dementia J Neurol Neurosurg Psychiatry 80 2009 562
18. J.C. Corvol, C. Bonnet, and F. Charbonnier-Beaupel The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: a randomized crossover clinical trial Ann Neurol 69 2011 111 118
19. D.J. Brooks, and N. Pavese Recent imaging advances in the diagnosis and management of Parkinson's disease F1000 Rep 1 2009 82 10.3410/M1-82
20. S.M. Rosso, L. Donker Kaat, and T. Baks Frontotemporal dementia in the Netherlands: patient characteristics and prevalence estimates from a population-based study Brain 126 2003 2016
21. B. Ravina, C. Tanner, and D. DiEulis A longitudinal program for biomarker development in Parkinson's disease: a feasibility study Mov Disord 24 14 2009 2081 2090